SONN Sonnet BioTherapeutics Holdings Inc.: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik Sonnet BioTherapeutics Holdings, Inc. (SONN)

The pursuit of agreements with pharma behemoths is driving growth, as evidenced by the current price-to-sales valuation of Sonnet BioTherapeutics (SONN). 8670.00 reflects the most recent value of this metric. The business foundation is the FHAB platform, which extends cytokine activity via albumin. Top biochemists lead the development, supported by substantial funding and comprehensive benefits packages. This chart helps identify zones of fundamental undervaluation or overvaluation of SONN assets.

Nilai perusahaan marang pendapatan: Sonnet BioTherapeutics Holdings Inc. (SONN) kanggo 23.11.2025 - 13.12.2025

Sonnet BioTherapeutics Holdings Inc. - rincian analitis lan metrik utama (SONN)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Sonnet BioTherapeutics Holdings, Inc. SONN
Sampel barang Sonnet BioTherapeutics Holdings, Inc.

For Sonnet BioTherapeutics (SONN), this indicator links market capitalization to the monetization efficiency of unique protein modification methods in immunotherapy. By analyzing the historical EV/Sales trend, an investor assesses the total enterprise value minus net debt relative to revenue, where sharp deviations of the curve from fundamentals signal speculative overheating and the risk of an asset correction.

Analisis pesaing Sonnet BioTherapeutics

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|werewolftx.com (HOWL) - Multiplikator nilai perusahaan marang pendapatan|Immix Biopharma Inc. - Multiplikator EV/Sales|ALXO - Multiplikator EV/Sales|CUE: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PDSB|MAIA (MAIABiotech.com) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Liminatus Pharma (LIMN)|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP